Graf Akcie ICPT (Intercept Pharmaceuticals Inc). Diskuze k akciím ICPT. Aktuální informace ICPT.

Základní informace o společnosti Intercept Pharmaceuticals Inc (Akcie ICPT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 557.79M
Hodnota podniku (EV) 662.73M
Tržby 341.026M
EBITDA -106.52
Zisk -170.13
Růst v tržbách Q/Q 25.02 %
Růst v tržbách Y/Y 20.35 %
P/E (Cena vůči ziskům) N/A
Forward P/E -11.32
EV/Sales 1.94
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.62
Price/Sales 1.64
P/FCF N/A
Price/Book -3.34
Účetní hodnota na akcii -5.03
Hotovost na akcii 14.39
FCF vůči ceně -19.76 %
Počet zaměstnanců 498
Tržba na zaměstnance 684.791k
Profit margin -87.91 %
Operating margin -36.46 %
Gross margin 98.30 %
EBIT margin -35.42 %
EBITDA margin -31.23 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -82.81 %
EPS - Očekávaný růst příští rok -44.28 %
Return on assets -30.72 %
Return on equity 97.17 %
ROIC -33.97 %
ROCE -31.96 %
Dluhy/Equity -4.48
Čistý dluh/EBITDA -4.16
Current ratio 3.39
Quick Ratio 3.33
Volatilita 5.09
Beta 1.12
RSI 58.38
Cílová cena analytiků 56
Známka akcie (dle analytiků) 2.39
Insider ownership 15.36 %
Institutional ownership 76.37 %
Počet akcií 33.201M
Procento shortovaných akcií 23.75 %
Short ratio 5.65 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2012
Země United States

Finanční výsledky akcie ICPT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$252.002$179.804$130.956$24.951$2.782$1.742
Cost Of Goods Sold$4.212$2.519$1.371---
Gross Profit$247.79$177.285$129.585$24.951$2.782$1.742
Research And Development Expenses$242.799$207.301$191.499$153.893$112.696$80.311
SG&A Expenses$317.418$255.474$273.698$273.596$119.242$34.601
Other Operating Income Or Expenses------
Operating Expenses$564.429$465.294$466.568$427.489$231.938$114.912
Operating Income$-312.427$-285.49$-335.612$-402.538$-229.156$-113.17
Total Non-Operating Income/Expense$-32.254$-23.752$-24.755$-10.292$2.727$-170.056
Pre-Tax Income$-344.681$-309.242$-360.367$-412.83$-226.429$-283.226
Income Taxes------
Income After Taxes$-344.681$-309.242$-360.367$-412.83$-226.429$-283.226
Other Income------
Income From Continuous Operations$-344.681$-309.242$-360.367$-412.83$-226.429$-283.226
Income From Discontinued Operations------
Net Income$-344.681$-309.242$-360.367$-412.83$-226.429$-283.226
EBITDA$-285.747$-265.368$-313.261$-386.841$-221.163$-109.361
EBIT$-312.427$-285.49$-335.612$-402.538$-229.156$-113.17
Basic Shares Outstanding322825252421
Shares Outstanding322825252421
Basic EPS$-10.89$-10.86$-14.38$-16.74$-9.56$-13.63
EPS - Earnings Per Share$-10.89$-10.86$-14.38$-16.74$-9.56$-13.63
# 2020 2019 2018 2017 2016 2015
Current Ratio4.45244.22424.30929.01613.545516.1294
Long-term Debt / Capital0.91170.9510.9560.5201--
Debt/Equity Ratio10.476319.797422.16231.107--
Gross Margin98.328698.59998.9531100100100
Operating Margin-123.978-158.7784-256.2785-1613.314-8237.095-6496.556
EBIT Margin-123.978-158.7784-256.2785-1613.314-8237.095-6496.556
EBITDA Margin-113.3908-147.5874-239.2109-1550.403-7949.784-6277.899
Pre-Tax Profit Margin-136.7771-171.9884-275.1817-1654.563-8139.072-16258.67
Net Profit Margin-136.7771-171.9884-275.1817-1654.563-8139.072-16258.67
Asset Turnover0.33380.35310.27040.03380.00420.0069
Inventory Turnover Ratio------
Receiveable Turnover6.6246.99797.93622.7341--
Days Sales In Receivables55.10352.158545.9915133.5013--
ROE - Return On Equity-668.5572-1616.526-2199.238-131.0854-37.6035-122.6671
Return On Tangible Equity-668.5569-1616.529-2199.239-131.0854-37.6035-122.6665
ROA - Return On Assets-45.66-60.7349-74.4027-55.8442-34.5294-111.4409
ROI - Return On Investment-59.0577-79.2156-96.8565-62.9038-37.6035-122.6665
Book Value Per Share1.56930.64420.650912.688624.687310.7817
Operating Cash Flow Per Share0.98182.13643.2916-7.0096-2.6538-2.668
Free Cash Flow Per Share0.95182.54533.0827-6.965-2.6809-2.8011